Spectral AI Inc. (MDAI)
NASDAQ (CM) NASDAQ (CM) Primary 
Spectral AI adds two clinical trial sites to pivotal burn study
Spectral AI Inc (NASDAQ:MDAI) announced that it has added two US clinical trial sites to its 2024 burn study, the University of California San Diego and the University of Utah. The medical diagnostics company said the addition of these new locations expands the total number of US clinical trial sites to 14.
Spectral AI achieves full pediatric enrollment in pivotal burn study
Spectral AI Inc (NASDAQ:MDAI), a company specializing in AI-driven medical diagnostics, has announced the completion of pediatric patient enrollment for its 2024 pivotal study. The study aims to validate the AI algorithm of its DeepView System for burn indications and is set to conclude in the fourth quarter of 2024.
Spectral AI joins Russell Microcap Index
Spectral AI Inc (NASDAQ:MDAI), the wound care diagnostics specialist, has been included in the Russell Microcap Index following the annual Russell Reconstitution, which took effect after the market close on June 28, 2024. The reconstituted Russell Microcap Index will commence trading on July 1, 2024.
Spectral AI near full enrollment of pediatric patients in burn study
Spectral AI Inc (NASDAQ:MDAI) announced it surpassed 90% of its enrollment target for pediatric patients at burn centers for its late-stage study evaluating its AI-driven DeepView System. The company's DeepView System utilizes proprietary multispectral imaging to distinguish between healthy and damaged tissue and can be used upon a child's arrival at the emergency department or burn center to provide immediate and accurate wound assessments in support of timely clinical decision-making for burn injuries.
Spectral AI supports naked short selling probe
Spectral AI Inc (NASDAQ:MDAI) told investors that it has provided support to Nasdaq and the state securities authorities in Florida, Louisiana and Texas to bring their attention to the potential market manipulation of the company's stock, primarily in the form of naked short selling. The company said the inquiry is being led by Erich Spangenberg, a member of its board of directors and its largest shareholder.
Spectral AI reaches enrollment milestone for pivotal DeepView System study at US burn centers
Spectral AI Inc (NASDAQ:MDAI) announced that it has achieved 50% clinical trial site enrollment for its pivotal Deepview System study. The DeepView System's image processing algorithm uses multispectral imaging, which has been trained on a proprietary database of more than 340 billion data points, to aid healthcare providers in assessing the healing potential of a burn wound.
Spectral AI to join Russell Microcap Index
Spectral AI Inc (NASDAQ:MDAI) an artificial intelligence company specializing in medical diagnostics for wound care, is set to join the Russell Microcap Index. The Russell Microcap Index is designed to represent the microcap segment of the U.S.
Spectral AI executives acquire shares as company advances AI wound care technology
Spectral AI Inc (NASDAQ:MDAI) announced that several of its officers and directors acquired approximately 113,000 shares of Spectral AI common stock in open market transactions in May. These transactions were made publicly and not through private arrangements, which can indicate confidence in the company's future prospects by its leadership.
